Reik Löser

No ORCID on file · 1 paper in corpus
other 2011
Expert opinion on therapeutic patents ·doi:10.1517/13543776.2011.550574

This article evaluates a patent application of the company Medivir (SE/UK) describing the synthesis of dipeptide-derived α-ketoamides containing a propylene glycine moiety in P1 as selective inhibitors of cathepsin S for the potential treat…